Article info
PDFORIGINAL ARTICLE
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model
- Address correspondence and reprint requests to: Karen H. Lu, MD, Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1155 Herman P. Pressler Street, Houston, TX 77030, USA. Email: khlu{at}mdanderson.org
Citation
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model
Publication history
- First published February 1, 2008.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2008 Blackwell Publishing Ltd.